Drug use in patients with dementia: a register-based study in the health region of Girona (Catalonia/Spain) Pilar Àvila-CastellsJosep Garre-Olmoon behalf of the Registry Dementia of Girona Study Group Review Article 23 November 2012 Pages: 1047 - 1056
A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity Zahra Nasiri-ToosiSimin Dashti-KhavidakiMahboob Lessan-Pezeshki Review Article 22 November 2012 Pages: 1057 - 1073
Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus Gozde KanmazOmer ErdeveUğur Dilmen Clinical Trial 06 November 2012 Pages: 1075 - 1081
Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy volunteers: headache, back pain, tolerability and measured acetylcholine profile Izaak den DaasJohan WemerAnthony R. Absalom Clinical Trial 10 November 2012 Pages: 1083 - 1090
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy Junichi AzumaMasako OhnoPharmacogenetics-based tuberculosis therapy research group Pharmacogenetics Open access 14 November 2012 Pages: 1091 - 1101
Effect of the CYP2C19*2 and *3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention Xiao-Fang TangJing WangYue-Jin Yang Pharmacogenetics 14 November 2012 Pages: 1103 - 1112
Influence of ORM1 polymorphisms on the maintenance stable warfarin dosage Lian Sheng WangJing Jing ShangHai Tang Xie Pharmacogenetics 04 December 2012 Pages: 1113 - 1120
Calcium bioavailability of calcium L-threonate in healthy Chinese subjects measured with stable isotopes (44Ca and 42Ca) Hongyun WangPei HuJi Jiang Pharmacokinetics and Disposition 16 November 2012 Pages: 1121 - 1126
Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studies Silke C. MuellerBernd Drewelow Pharmacokinetics and Disposition 07 November 2012 Pages: 1127 - 1134
A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray C. G. StottL. WhiteG. W. Guy Pharmacokinetics and Disposition 22 November 2012 Pages: 1135 - 1147
Pharmacokinetics of teduglutide in subjects with renal impairment Rüdiger NaveAtef HalabiManfred Hartmann Pharmacokinetics and Disposition 28 November 2012 Pages: 1149 - 1155
Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison Marta HerranzSusana Morales-AlcelayAlfredo García-Arieta Pharmacokinetics and Disposition 30 November 2012 Pages: 1157 - 1162
Categorising paediatric prescribing errors by junior doctors through prescribing competency assessment: does assessment reflect actual practice? Tessa DavisHong ThoongGuy Makin Pharmacoepidemiology and Prescription 10 November 2012 Pages: 1163 - 1166
Danish physicians’ preferences for prescribing escitalopram over citalopram and sertraline to treatment-naïve patients: a national, register-based study Karen Killerup PoulsenDorte GlintborgStig Ejdrup Andersen Pharmacoepidemiology and Prescription 06 November 2012 Pages: 1167 - 1171
Social stratification in the dissemination of statins after stroke in Sweden Maria SjölanderMarie ErikssonEva-Lotta Glader Pharmacoepidemiology and Prescription 28 November 2012 Pages: 1173 - 1180
Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children Wei ZhaoAnne MaisinEvelyne Jacqz-Aigrain Short Communication 04 December 2012 Pages: 1181 - 1185
The reproducibility of bolus allergen challenges; power calculations for clinical trials Raminder AulHayley KingDave Singh Letter to the Editors 06 November 2012 Pages: 1187 - 1188
Bringing pharmacogenetics to the bedside Ankur Gupta Letter to the Editors 09 November 2012 Pages: 1189 - 1190
Personalizing antiplatelet therapy-moving to clinics Subraja KumaresanSteven Dkhar Letter to the Editors 13 November 2012 Pages: 1191 - 1191
Gamma-hydroxybutyrate (GHB) and topiramate—clinically relevant drug interaction suggested by a case of coma and increased plasma GHB concentration Tobias WeissDaniel MüllerStefan Russmann Letter to the Editors 17 November 2012 Pages: 1193 - 1194
Memory impairment associated with varenicline Ming TanMira Harrison-Woolrych Letter to the Editors 12 December 2012 Pages: 1195 - 1196
